Technical Analysis for IMAB - I-Mab
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.10 | 2.80% | 0.03 |
IMAB closed unchanged on Friday, November 1, 2024, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 14
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 2.80% | |
| Lower Bollinger Band Walk | Weakness | 2.80% | |
| Wide Bands | Range Expansion | 2.80% | |
| Oversold Stochastic | Weakness | 2.80% | |
| Lower Bollinger Band Walk | Weakness | 2.80% | |
| Wide Bands | Range Expansion | 2.80% | |
| Down 3 Days in a Row | Weakness | 2.80% | |
| Lower Bollinger Band Touch | Weakness | 2.80% | |
| Oversold Stochastic | Weakness | 2.80% | |
| 50 DMA Resistance | Bearish | -0.90% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | about 3 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
| Up 5% | about 4 hours ago |
| Up 3% | about 4 hours ago |
| Up 2% | about 4 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/14/2024
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.5362 |
| 52 Week Low | 0.99 |
| Average Volume | 391,709 |
| 200-Day Moving Average | 1.56 |
| 50-Day Moving Average | 1.21 |
| 20-Day Moving Average | 1.30 |
| 10-Day Moving Average | 1.22 |
| Average True Range | 0.12 |
| RSI (14) | 38.65 |
| ADX | 26.94 |
| +DI | 18.05 |
| -DI | 20.54 |
| Chandelier Exit (Long, 3 ATRs) | 1.28 |
| Chandelier Exit (Short, 3 ATRs) | 1.41 |
| Upper Bollinger Bands | 1.58 |
| Lower Bollinger Band | 1.03 |
| Percent B (%b) | 0.08 |
| BandWidth | 42.20 |
| MACD Line | -0.04 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.042 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.19 | ||||
| Resistance 3 (R3) | 1.20 | 1.16 | 1.17 | ||
| Resistance 2 (R2) | 1.16 | 1.13 | 1.16 | 1.16 | |
| Resistance 1 (R1) | 1.12 | 1.11 | 1.10 | 1.11 | 1.16 |
| Pivot Point | 1.08 | 1.08 | 1.07 | 1.08 | 1.08 |
| Support 1 (S1) | 1.04 | 1.05 | 1.02 | 1.03 | 0.98 |
| Support 2 (S2) | 1.00 | 1.03 | 1.00 | 0.98 | |
| Support 3 (S3) | 0.96 | 1.00 | 0.97 | ||
| Support 4 (S4) | 0.95 |
